Albertine Scheltema Beduin

Learn More
Substance abuse and psychotic disorders have a high rate of comorbidity. Both disorders are associated with changes in the dopaminergic transmission in the mesocorticolimbic pathways of the brain. Since antipsychotic medications interact with the dopamine receptors in these pathways, these medications could affect craving for substances. In the current(More)
  • Marise Beduin, Albertine Scheltema, +11 authors Durk Wiersma
  • 2017
Outcome Psychosis Grp (2012). Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under(More)
  • 1